Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

TXK

RBC: TXK · Substrate: ABLtide ·

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Canertinib100.00.67
Ibrutinib99.90.72
Repotrectinib99.80.61
Dasatinib99.10.70
Entrectinib99.10.67
Dacomitinib97.90.66
Osimertinib97.60.73
Bosutinib97.20.55
Mobocertinib97.10.76
Lazertinib97.00.67
Zanubrutinib96.90.79
Ponatinib95.30.53
Afatinib93.00.71
Nintedanib90.70.61
Pralsetinib87.80.64

Known variants

No variants catalogued.
Open in new tab